Sysmex Corporation (SSMXY)
USD 18.76
(-0.27%)
USD 18.76
(-0.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 186.02 Billion JPY | 30.35% |
| 2023 | 142.71 Billion JPY | 5.79% |
| 2022 | 134.89 Billion JPY | 13.4% |
| 2021 | 118.95 Billion JPY | 7.22% |
| 2020 | 110.94 Billion JPY | 35.98% |
| 2019 | 81.58 Billion JPY | 1.31% |
| 2018 | 80.53 Billion JPY | 13.03% |
| 2017 | 71.24 Billion JPY | -14.02% |
| 2016 | 82.86 Billion JPY | 5.65% |
| 2015 | 78.43 Billion JPY | 21.58% |
| 2014 | 64.5 Billion JPY | 19.78% |
| 2013 | 53.85 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 137.71 Billion JPY | 3.71% |
| 2024 FY | 186.02 Billion JPY | 30.34% |
| 2024 Q3 | 160.27 Billion JPY | 16.38% |
| 2024 Q4 | 186.02 Billion JPY | 16.07% |
| 2024 Q1 | 132.78 Billion JPY | -6.96% |
| 2023 Q4 | 142.71 Billion JPY | 12.06% |
| 2023 Q2 | 130.83 Billion JPY | 4.78% |
| 2023 Q1 | 124.86 Billion JPY | -7.44% |
| 2023 FY | 142.71 Billion JPY | 5.79% |
| 2023 Q3 | 127.35 Billion JPY | -2.67% |
| 2022 Q2 | 119.46 Billion JPY | 7.34% |
| 2022 FY | 134.89 Billion JPY | 13.4% |
| 2022 Q3 | 128.19 Billion JPY | 7.3% |
| 2022 Q4 | 134.89 Billion JPY | 5.23% |
| 2022 Q1 | 111.29 Billion JPY | -6.32% |
| 2021 Q3 | 101.23 Billion JPY | 6.75% |
| 2021 Q2 | 94.83 Billion JPY | 2.5% |
| 2021 FY | 118.95 Billion JPY | 7.22% |
| 2021 Q1 | 92.52 Billion JPY | -16.6% |
| 2021 Q4 | 118.8 Billion JPY | 17.35% |
| 2020 Q1 | 93.22 Billion JPY | 14.25% |
| 2020 Q4 | 110.94 Billion JPY | 11.09% |
| 2020 Q3 | 99.87 Billion JPY | 4.07% |
| 2020 Q2 | 95.97 Billion JPY | 2.95% |
| 2020 FY | 110.94 Billion JPY | 35.98% |
| 2019 Q1 | 56.89 Billion JPY | -29.35% |
| 2019 Q3 | 61.77 Billion JPY | 0.64% |
| 2019 Q4 | 81.59 Billion JPY | 32.08% |
| 2019 Q2 | 61.38 Billion JPY | 7.88% |
| 2019 FY | 81.58 Billion JPY | 1.31% |
| 2018 Q4 | 80.53 Billion JPY | 24.38% |
| 2018 FY | 80.53 Billion JPY | 13.03% |
| 2018 Q1 | 59.25 Billion JPY | -14.82% |
| 2018 Q2 | 67.05 Billion JPY | 13.16% |
| 2018 Q3 | 64.74 Billion JPY | -3.44% |
| 2017 Q1 | 50.38 Billion JPY | -36.65% |
| 2017 Q2 | 55.46 Billion JPY | 10.07% |
| 2017 Q4 | 69.56 Billion JPY | 22.67% |
| 2017 Q3 | 56.71 Billion JPY | 2.25% |
| 2017 FY | 71.24 Billion JPY | -14.02% |
| 2016 FY | 82.86 Billion JPY | 5.65% |
| 2016 Q4 | 79.54 Billion JPY | 38.45% |
| 2016 Q3 | 57.45 Billion JPY | -2.16% |
| 2016 Q2 | 58.72 Billion JPY | 10.73% |
| 2016 Q1 | 53.03 Billion JPY | -32.38% |
| 2015 Q4 | 78.43 Billion JPY | 37.92% |
| 2015 Q3 | 56.86 Billion JPY | -11.78% |
| 2015 Q2 | 64.46 Billion JPY | 13.08% |
| 2015 Q1 | 57 Billion JPY | -11.63% |
| 2015 FY | 78.43 Billion JPY | 21.58% |
| 2014 FY | 64.5 Billion JPY | 19.78% |
| 2014 Q4 | 64.5 Billion JPY | 8.31% |
| 2014 Q3 | 59.56 Billion JPY | 18.04% |
| 2014 Q2 | 50.45 Billion JPY | 34.91% |
| 2014 Q1 | 37.39 Billion JPY | -30.56% |
| 2013 Q4 | 53.85 Billion JPY | 28.54% |
| 2013 Q2 | 38.36 Billion JPY | 0.0% |
| 2013 FY | 53.85 Billion JPY | 0.0% |
| 2013 Q3 | 41.89 Billion JPY | 9.2% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -7916170.186% |
| Ansell Limited | 1.32 Billion USD | -13887.453% |
| Ansell Limited | 1.33 Billion USD | -13861.273% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -147140.233% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -19722707.717% |
| Psykey, Inc. | 2.47 Million USD | -7518839.83% |
| ConvaTec Group Plc | 2.01 Billion USD | -9117.369% |
| ConvaTec Group Plc | 2.02 Billion USD | -9104.354% |
| Encision Inc. | 1.98 Million USD | -9376059.293% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -6118014.942% |
| Innovative MedTech Inc. | 6.13 Million USD | -3032088.436% |
| LifePoint, Inc. | 2.45 Million USD | -7579655.102% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -1827028.966% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -5471076.471% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -6118328.864% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -23961390.554% |
| SmileDirectClub, Inc. | 982.26 Million USD | -18837.94% |
| Sector 10, Inc. | 9.84 Million USD | -1889304.91% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | -13621.262% |
| SheerVision, Inc. | 1.43 Million USD | -12995541.339% |
| United Health Products, Inc. | 1.99 Million USD | -9306162.692% |
| Vasamed, Inc. | 1 Million USD | -18503829.175% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -4894796.041% |
| Yubo International Biotech Limited | 2.91 Million USD | -6383731.562% |